News Briefs: Medtronic’s First-Gen Artificial Pancreas Approved; CMS Removes Bariatric Surgery Requirements
This article was originally published in The Gray Sheet
Executive Summary
FDA approves Medtronic’s MiniMed 530G system, making it the first system in the U.S. that can automatically suspend insulin delivery to people with diabetes. CMS removes bariatric surgery facility certification requirements. More news.
You may also be interested in...
People Briefs: MDMA Board Adds; Appointments At Insulet, MedLumics, Cardiva, Cardica
Industry veteran Jim Mazzo joins Medical Device Manufacturers Association board, along with three others. Insulet, MedLumics, Cardiva and Cardica announce appointments. More people briefs.
Insulin Pumps, Including Sensor-Augmented, Enter Competitive Bidding
Now that insulin pumps are part of CMS’ competitive bidding program, there is a possibility of reimbursement reductions down the road. And in a separate process, CMS denied Medtronic’s request to establish a new HCPCS code for sensor-augmented insulin pumps.
Medtronic Anticipates Turnaround For Challenged Business Units
Executives focused on new developments in the company’s ICD, spine, neuromodulation, and diabetes product lines, which have each faced particular challenges over the past year, during Medtronic’s second-quarter fiscal 2014 earnings call.